MannKind | MNKD - Costo Del Venduto





Costo Del Venduto Cambiamento Data
Adma Biologics USD 50.4M 8.24M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Insmed USD 46.16M 15.25M 2025-12
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
MacroGenics USD 10.12M 34.18M 2025-12
MannKind USD 33.65M 13.44M 2025-12
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Novavax USD 22.1M 608K 2025-12
Novo Nordisk DKK 1.95B 10.94B 2025-06
Pfizer USD 6.29B 2.12B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Xencor USD 61.66M 50.95M 2025-06